{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,30]],"date-time":"2025-12-30T06:07:18Z","timestamp":1767074838724,"version":"3.48.0"},"reference-count":66,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,30]],"date-time":"2025-12-30T00:00:00Z","timestamp":1767052800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,12,30]],"date-time":"2025-12-30T00:00:00Z","timestamp":1767052800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100004837","name":"Ministerio de Ciencia e Innovaci\u00f3n","doi-asserted-by":"publisher","award":["PID2021\u2010126781OB\u2010I00"],"award-info":[{"award-number":["PID2021\u2010126781OB\u2010I00"]}],"id":[{"id":"10.13039\/501100004837","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Fundaci\u00f3n Universidad Alfonso X el Sabio - Santander","award":["1.010.932"],"award-info":[{"award-number":["1.010.932"]}]},{"name":"Centro de Investigaci\u00f3n Biom\u00e9dica en Red en Enfermedades Infecciosas","award":["CB21\/13\/00044"],"award-info":[{"award-number":["CB21\/13\/00044"]}]},{"name":"Centro de Investigaci\u00f3n Biom\u00e9dica en Red en Enfermedades Infecciosas","award":["CB21\/13\/00107"],"award-info":[{"award-number":["CB21\/13\/00107"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Transl Med"],"DOI":"10.1186\/s12967-025-07070-5","type":"journal-article","created":{"date-parts":[[2025,12,30]],"date-time":"2025-12-30T04:00:10Z","timestamp":1767067210000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["IFNL4-rs12979860 CC genotype predisposes to accelerated terminal exhaustion and senescence in HIV\/HCV-chronic infection"],"prefix":"10.1186","volume":"23","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4750-0988","authenticated-orcid":false,"given":"Sonia","family":"Arca-Lafuente","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0015-5961","authenticated-orcid":false,"given":"Violeta","family":"Lara-Aguilar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3855-5872","authenticated-orcid":false,"given":"Manuel","family":"Llamas-Ad\u00e1n","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6910-5017","authenticated-orcid":false,"given":"Sergio","family":"Grande-Garc\u00eda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andr\u00e9s","family":"Deza de la Casa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8102-4079","authenticated-orcid":false,"given":"Luz","family":"Mart\u00edn-Carbonero","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4212-7419","authenticated-orcid":false,"given":"Pablo","family":"Ryan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7073-5211","authenticated-orcid":false,"given":"Ignacio","family":"de los Santos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mariano","family":"Matarranz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1945-6169","authenticated-orcid":false,"given":"M\u00aa \u00c1ngeles","family":"Jim\u00e9nez-Sousa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5110-2213","authenticated-orcid":false,"given":"Amanda","family":"Fern\u00e1ndez-Rodr\u00edguez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2297-5098","authenticated-orcid":false,"given":"Ver\u00f3nica","family":"Briz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,12,30]]},"reference":[{"key":"7070_CR1","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1016\/S1473-3099(15)00485-5","volume":"16","author":"L Platt","year":"2016","unstructured":"Platt L, Easterbrook P, Gower E, McDonald B, Sabin K, McGowan C, et al. Prevalence and burden of HCV co-infection in people living with HIV: a global systematic review and meta-analysis. Lancet Infect Dis. 2016;16:797\u201308.","journal-title":"Lancet Infect Dis"},{"key":"7070_CR2","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1097\/QAD.0000000000002156","volume":"33","author":"N Kronfli","year":"2019","unstructured":"Kronfli N, Bhatnagar SR, Hull MW, Moodie EEM, Cox J, Walmsley S, et al. Trends in cause-specific mortality in HIV-hepatitis C coinfection following hepatitis C treatment scale-up. AIDS. 2019;33:1013\u201322.","journal-title":"AIDS"},{"key":"7070_CR3","doi-asserted-by":"publisher","first-page":"680","DOI":"10.1111\/jvh.12866","volume":"25","author":"DN Aisyah","year":"2018","unstructured":"Aisyah DN, Shallcross L, Hully AJ, O\u2019Brien A, Hayward A. Assessing hepatitis C spontaneous clearance and understanding associated factors-a systematic review and meta-analysis. J Viral Hepat. 2018;25:680\u201398.","journal-title":"J Viral Hepat"},{"key":"7070_CR4","doi-asserted-by":"publisher","first-page":"798","DOI":"10.1038\/nature08463","volume":"461","author":"DL Thomas","year":"2009","unstructured":"Thomas DL, Thio CL, Martin MP, Qi Y, Ge D, O\u2019Huigin C, et al. Genetic variation in IL28B and spontaneous clearance of hepatitis C virus. Nature. 2009;461:798\u201301.","journal-title":"Nature"},{"key":"7070_CR5","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinre.2020.06.006","volume":"45","author":"MA El-Fattah","year":"2021","unstructured":"El-Fattah MA. Predictive power of Interleukin-28B gene variants for outcome of Hepatitis C Virus genotype 4 in Egyptians: a systematic review and meta-analysis. Clin Res Hepatol Gastroenterol. 2021;45:101480.","journal-title":"Clin Res Hepatol Gastroenterol"},{"key":"7070_CR6","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1186\/1741-7015-11-6","volume":"11","author":"MA Jimenez-Sousa","year":"2013","unstructured":"Jimenez-Sousa MA, Fernandez-Rodriguez A, Guzman-Fulgencio M, Garcia-Alvarez M, Resino S. Meta-analysis: implications of interleukin-28B polymorphisms in spontaneous and treatment-related clearance for patients with hepatitis C. BMC Med. 2013;11:6.","journal-title":"BMC Med"},{"key":"7070_CR7","doi-asserted-by":"publisher","DOI":"10.26508\/lsa.201900612","author":"M Coto-Llerena","year":"2020","unstructured":"Coto-Llerena M, Lepore M, Spagnuolo J, Di Blasi D, Calabrese D, Suslov A, et al. Interferon lambda 4 can directly activate human CD19(+) B cells and CD8(+) T cells. Life Sci Alliance. 2020. https:\/\/doi.org\/10.26508\/lsa.201900612.","journal-title":"Life Sci Alliance"},{"key":"7070_CR8","doi-asserted-by":"publisher","first-page":"2469","DOI":"10.1007\/s00705-021-05141-8","volume":"166","author":"HH Miri","year":"2021","unstructured":"Miri HH, Fazeli P, Ali-Hassanzadeh M, Bemani P, Kabelitz D, Kalantar K. Correlation between IL-28 polymorphism and spontaneous clearance in HCV patients: systematic review and meta-analysis. Arch Virol. 2021;166:2469\u201378.","journal-title":"Arch Virol"},{"key":"7070_CR9","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1038\/nri1573","volume":"5","author":"B Rehermann","year":"2005","unstructured":"Rehermann B, Nascimbeni M. Immunology of hepatitis B virus and hepatitis C virus infection. Nat Rev Immunol. 2005;5:215\u201329.","journal-title":"Nat Rev Immunol"},{"key":"7070_CR10","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0173943","volume":"12","author":"N Rallon","year":"2017","unstructured":"Rallon N, Garcia M, Garcia-Samaniego J, Rodriguez N, Cabello A, Restrepo C, et al. HCV coinfection contributes to HIV pathogenesis by increasing immune exhaustion in CD8 T-cells. PLoS ONE. 2017;12:e0173943.","journal-title":"PLoS ONE"},{"key":"7070_CR11","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1007\/s40139-013-0024-9","volume":"1","author":"T Wang","year":"2013","unstructured":"Wang T, Weinman SA. Interactions between hepatitis C virus and mitochondria: impact on pathogenesis and innate immunity. Curr Pathobiol Rep. 2013;1:179\u201387.","journal-title":"Curr Pathobiol Rep"},{"key":"7070_CR12","doi-asserted-by":"crossref","unstructured":"C\u00f4t\u00e9 HCF, Department of Pathology and Laboratory Medicine UoBC, Centre for Blood Research V, Canada, Women\u2019s Health Research Institute V, Canada, Hsieh AYY, Department of Pathology and Laboratory Medicine UoBC, et al. Leukocyte Telomere Length in HIV Infection: A Marker of Persistent Immune Aging or Transient Immune Reconstitution? The Journal of Infectious Diseases. 2024;218:1521\u20132.","DOI":"10.1093\/infdis\/jiy365"},{"key":"7070_CR13","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1016\/j.jhep.2010.03.005","volume":"53","author":"M Hoare","year":"2010","unstructured":"Hoare M, Gelson WT, Das A, Fletcher JM, Davies SE, Curran MD, et al. CD4+ t-lymphocyte telomere length is related to fibrosis stage, clinical outcome and treatment response in chronic hepatitis C virus infection. J Hepatol. 2010;53:252\u201360.","journal-title":"J Hepatol"},{"key":"7070_CR14","doi-asserted-by":"publisher","first-page":"63","DOI":"10.3389\/fmolb.2020.00063","volume":"7","author":"JP Vernot","year":"2020","unstructured":"Vernot JP. Senescence-associated pro-inflammatory cytokines and tumor cell plasticity. Front Mol Biosci. 2020;7:63.","journal-title":"Front Mol Biosci"},{"key":"7070_CR15","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1146\/annurev-pathol-121808-102144","volume":"5","author":"JP Coppe","year":"2010","unstructured":"Coppe JP, Desprez PY, Krtolica A, Campisi J. The senescence-associated secretory phenotype: the dark side of tumor suppression. Annu Rev Pathol. 2010;5:99\u2013118.","journal-title":"Annu Rev Pathol"},{"key":"7070_CR16","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1016\/j.cyto.2014.10.030","volume":"71","author":"EJ Breen","year":"2015","unstructured":"Breen EJ, Polaskova V, Khan A. Bead-based multiplex immuno-assays for cytokines, chemokines, growth factors and other analytes: median fluorescence intensities versus their derived absolute concentration values for statistical analysis. Cytokine. 2015;71:188\u201398.","journal-title":"Cytokine"},{"key":"7070_CR17","doi-asserted-by":"publisher","first-page":"26996","DOI":"10.1038\/srep26996","volume":"6","author":"EJ Breen","year":"2016","unstructured":"Breen EJ, Tan W, Khan A. The statistical value of raw fluorescence signal in Luminex xMAP based multiplex immunoassays. Sci Rep. 2016;6:26996.","journal-title":"Sci Rep"},{"key":"7070_CR18","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.170767","author":"MR Shapiro","year":"2023","unstructured":"Shapiro MR, Dong X, Perry DJ, McNichols JM, Thirawatananond P, Posgai AL, et al. Human immune phenotyping reveals accelerated aging in type 1 diabetes. JCI Insight. 2023. https:\/\/doi.org\/10.1172\/jci.insight.170767.","journal-title":"JCI Insight"},{"key":"7070_CR19","doi-asserted-by":"crossref","unstructured":"Elgretli W, Division of Experimental Medicine MU, Montreal, QC H4A 3J1, Canada, Chen T, Division of Gastroenterology and Hepatology DoM, McGill University Health Centre, Montreal, QC H4A 3J1, Canada, Kronfli N, Department of Medicine DoIDaCVIS, McGill University Health Centre, Montreal, QC H4A 3J1, Canada, et al. Hepatitis C Virus-Lipid Interplay: Pathogenesis and Clinical Impact. Biomedicines. 2024;11:271.","DOI":"10.3390\/biomedicines11020271"},{"key":"7070_CR20","doi-asserted-by":"publisher","first-page":"1904","DOI":"10.1002\/hep.23592","volume":"51","author":"JH Li","year":"2010","unstructured":"Li JH, Lao XQ, Tillmann HL, Rowell J, Patel K, Thompson A, et al. Interferon-lambda genotype and low serum low-density lipoprotein cholesterol levels in patients with chronic hepatitis C infection. Hepatology. 2010;51:1904\u201311.","journal-title":"Hepatology"},{"key":"7070_CR21","doi-asserted-by":"crossref","unstructured":"Corey KE, Gastrointestinal Unit MGH, Boston, MA, Harvard Medical School B, MA, Kane E, Harvard Medical School B, MA, Munroe C, et al. 2024. Hepatitis C Virus Infection and Its Clearance Alter Circulating Lipids: Implications for Long Term Follow-up. Hepatology (Baltimore, Md).50:1030.","DOI":"10.1002\/hep.23219"},{"key":"7070_CR22","doi-asserted-by":"publisher","first-page":"1824","DOI":"10.1002\/hep.22242","volume":"47","author":"C Neumann-Haefelin","year":"2008","unstructured":"Neumann-Haefelin C, Timm J, Spangenberg HC, Wischniowski N, Nazarova N, Kersting N, et al. Virological and immunological determinants of intrahepatic virus-specific CD8+ T-cell failure in chronic hepatitis C virus infection. Hepatology. 2008;47:1824\u201336.","journal-title":"Hepatology"},{"key":"7070_CR23","doi-asserted-by":"publisher","first-page":"1741","DOI":"10.1084\/jem.20050121","volume":"201","author":"AL Cox","year":"2005","unstructured":"Cox AL, Mosbruger T, Mao Q, Liu Z, Wang XH, Yang HC, et al. Cellular immune selection with hepatitis C virus persistence in humans. J Exp Med. 2005;201:1741\u201352.","journal-title":"J Exp Med"},{"key":"7070_CR24","doi-asserted-by":"publisher","DOI":"10.3390\/cells8040305","author":"D Lapa","year":"2019","unstructured":"Lapa D, Garbuglia AR, Capobianchi MR, Del Porto P. Hepatitis C virus genetic variability, human immune response, and genome polymorphisms: which is the interplay? Cells. 2019. https:\/\/doi.org\/10.3390\/cells8040305.","journal-title":"Cells"},{"key":"7070_CR25","doi-asserted-by":"publisher","first-page":"1229","DOI":"10.1128\/JVI.75.3.1229-1235.2001","volume":"75","author":"DK Wong","year":"2001","unstructured":"Wong DK, Dudley DD, Dohrenwend PB, Lauer GM, Chung RT, Thomas DL, et al. Detection of diverse hepatitis C virus (HCV)-specific cytotoxic T lymphocytes in peripheral blood of infected persons by screening for responses to all translated proteins of HCV. J Virol. 2001;75:1229\u201335.","journal-title":"J Virol"},{"key":"7070_CR26","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2016.00628","volume":"7","author":"M Boisvert","year":"2016","unstructured":"Boisvert M, Shoukry NH. Type III interferons in hepatitis C virus infection. Front Immunol. 2016;7:628.","journal-title":"Front Immunol"},{"key":"7070_CR27","doi-asserted-by":"publisher","first-page":"4112","DOI":"10.4049\/jimmunol.178.7.4112","volume":"178","author":"P Romero","year":"2007","unstructured":"Romero P, Zippelius A, Kurth I, Pittet MJ, Touvrey C, Iancu EM, et al. Four functionally distinct populations of human effector-memory CD8+ T lymphocytes. J Immunol. 2007;178:4112\u20139.","journal-title":"J Immunol"},{"key":"7070_CR28","doi-asserted-by":"publisher","DOI":"10.3390\/cancers15184456","volume":"15","author":"K Mizoguchi","year":"2023","unstructured":"Mizoguchi K, Kawaji H, Kai M, Morisaki T, Hayashi S, Takao Y, et al. Granzyme B expression in the tumor microenvironment as a prognostic biomarker for patients with triple-negative breast cancer. Cancers (Basel). 2023;15:4456.","journal-title":"Cancers (Basel)"},{"key":"7070_CR29","doi-asserted-by":"crossref","unstructured":"Choi J, James Ou JH. Mechanisms of Liver Injury. III. Oxidative stress in the pathogenesis of hepatitis C virus. American Journal of Physiology-Gastrointestinal and Liver Physiology. 2006;290:G847-G51.","DOI":"10.1152\/ajpgi.00522.2005"},{"key":"7070_CR30","doi-asserted-by":"publisher","first-page":"6422","DOI":"10.1038\/ncomms7422","volume":"6","author":"M Eslam","year":"2015","unstructured":"Eslam M, Hashem AM, Leung R, Romero-Gomez M, Berg T, Dore GJ, et al. Interferon-lambda rs12979860 genotype and liver fibrosis in viral and non-viral chronic liver disease. Nat Commun. 2015;6:6422.","journal-title":"Nat Commun"},{"key":"7070_CR31","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1007\/s10875-011-9547-1","volume":"31","author":"E Falleti","year":"2011","unstructured":"Falleti E, Bitetto D, Fabris C, Cussigh A, Fornasiere E, Cmet S, et al. Role of interleukin 28B rs12979860 C\/T polymorphism on the histological outcome of chronic hepatitis C: relationship with gender and viral genotype. J Clin Immunol. 2011;31:891\u20139.","journal-title":"J Clin Immunol"},{"key":"7070_CR32","doi-asserted-by":"publisher","first-page":"1548","DOI":"10.1002\/hep.26506","volume":"58","author":"M Noureddin","year":"2013","unstructured":"Noureddin M, Wright EC, Alter HJ, Clark S, Thomas E, Chen R, et al. Association of IL28B genotype with fibrosis progression and clinical outcomes in patients with chronic hepatitis C: a longitudinal analysis. Hepatology. 2013;58:1548\u201357.","journal-title":"Hepatology"},{"key":"7070_CR33","doi-asserted-by":"publisher","DOI":"10.3390\/cells11142221","author":"P Wijayasiri","year":"2022","unstructured":"Wijayasiri P, Astbury S, Kaye P, Oakley F, Alexander GJ, Kendall TJ, et al. Role of hepatocyte senescence in the activation of hepatic stellate cells and liver fibrosis progression. Cells. 2022. https:\/\/doi.org\/10.3390\/cells11142221.","journal-title":"Cells"},{"key":"7070_CR34","doi-asserted-by":"publisher","first-page":"1256","DOI":"10.1111\/j.1440-1746.2006.04621.x","volume":"22","author":"F Tacke","year":"2007","unstructured":"Tacke F, Trautwein C, Yagmur E, Hellerbrand C, Wiest R, Brenner DA, et al. Up-regulated eotaxin plasma levels in chronic liver disease patients indicate hepatic inflammation, advanced fibrosis and adverse clinical course. J Gastroenterol Hepatol. 2007;22:1256\u201364.","journal-title":"J Gastroenterol Hepatol"},{"key":"7070_CR35","doi-asserted-by":"publisher","first-page":"1284293","DOI":"10.3389\/fimmu.2023.1284293","volume":"14","author":"L Guo","year":"2023","unstructured":"Guo L, Liu X, Su X. The role of TEMRA cell-mediated immune senescence in the development and treatment of HIV disease. Front Immunol. 2023;14:1284293.","journal-title":"Front Immunol"},{"key":"7070_CR36","doi-asserted-by":"publisher","first-page":"1189","DOI":"10.1093\/intimm\/dxn075","volume":"20","author":"R Okada","year":"2008","unstructured":"Okada R, Kondo T, Matsuki F, Takata H, Takiguchi M. Phenotypic classification of human CD4+ T cell subsets and their differentiation. Int Immunol. 2008;20:1189\u201399.","journal-title":"Int Immunol"},{"key":"7070_CR37","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a028464","author":"M Hashimoto","year":"2019","unstructured":"Hashimoto M, Im SJ, Araki K, Ahmed R. Cytokine-mediated regulation of CD8 T-cell responses during acute and chronic viral infection. Cold Spring Harb Perspect Biol. 2019. https:\/\/doi.org\/10.1101\/cshperspect.a028464.","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"7070_CR38","doi-asserted-by":"publisher","DOI":"10.1016\/j.cyto.2018.06.006","author":"F Vahedi","year":"2019","unstructured":"Vahedi F, Lee AJ, Collins SE, Chew MV, Lusty E, Chen B, et al. IL-15 and IFN-\u03b3 signal through the ERK pathway to inhibit HCV replication, independent of type I IFN signaling. Cytokine. 2019. https:\/\/doi.org\/10.1016\/j.cyto.2018.06.006.","journal-title":"Cytokine"},{"key":"7070_CR39","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1006\/cyto.1999.0530","volume":"12","author":"Vicente Carre\u00f1o","year":"2000","unstructured":"Carre\u00f1o Vicente, et al. Randomized controlled trial of recombinant human granulocyte-macrophage colony-stimulating factor for the treatment of chronic hepatitis C.\". Cytokine. 2000;12:165\u201370.","journal-title":"Cytokine"},{"key":"7070_CR40","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.cytogfr.2021.01.001","volume":"59","author":"M Petrina","year":"2021","unstructured":"Petrina M, Martin J, Basta S. Granulocyte macrophage colony-stimulating factor has come of age: from a vaccine adjuvant to antiviral immunotherapy. Cytokine Growth Factor Rev. 2021;59:101\u201310.","journal-title":"Cytokine Growth Factor Rev"},{"key":"7070_CR41","doi-asserted-by":"publisher","first-page":"5297","DOI":"10.3748\/wjg.v24.i47.5297","volume":"24","author":"H Li","year":"2018","unstructured":"Li H, Huang MH, Jiang JD, Peng ZG. Hepatitis C: from inflammatory pathogenesis to anti-inflammatory\/hepatoprotective therapy. World J Gastroenterol. 2018;24:5297\u2013311.","journal-title":"World J Gastroenterol"},{"key":"7070_CR42","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1086\/317537","volume":"32","author":"B Spellberg","year":"2001","unstructured":"Spellberg B, Edwards JE Jr. Type 1\/type 2 immunity in infectious diseases. Clin Infect Dis. 2001;32:76\u2013102.","journal-title":"Clin Infect Dis"},{"key":"7070_CR43","doi-asserted-by":"publisher","first-page":"5492","DOI":"10.4049\/jimmunol.154.10.5492","volume":"154","author":"AE Chernoff","year":"1995","unstructured":"Chernoff AE, Granowitz EV, Shapiro L, Vannier E, Lonnemann G, Angel JB, et al. A randomized, controlled trial of IL-10 in humans. Inhibition of inflammatory cytokine production and immune responses. J Immunol. 1995;154:5492\u20139.","journal-title":"J Immunol"},{"key":"7070_CR44","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1007\/BF01541395","volume":"16","author":"AC Fuchs","year":"1996","unstructured":"Fuchs AC, Granowitz EV, Shapiro L, Vannier E, Lonnemann G, Angel JB, et al. Clinical, hematologic, and immunologic effects of interleukin-10 in humans. J Clin Immunol. 1996;16:291\u201303.","journal-title":"J Clin Immunol"},{"key":"7070_CR45","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1146\/annurev-immunol-031210-101312","volume":"29","author":"W Ouyang","year":"2011","unstructured":"Ouyang W, Rutz S, Crellin NK, Valdez PA, Hymowitz SG. Regulation and functions of the IL-10 family of cytokines in inflammation and disease. Annu Rev Immunol. 2011;29:71\u2013109.","journal-title":"Annu Rev Immunol"},{"key":"7070_CR46","doi-asserted-by":"publisher","DOI":"10.1016\/j.aohep.2021.100638","author":"M Hernandez-Santillan","year":"2022","unstructured":"Hernandez-Santillan M, Mart\u00ednez-Castillo M, Santana-Vargas D, Medina-Avila Z, Hern\u00e1ndez-Barragan A, Lim\u00f3n-Castillo J, et al. Il-10 Y Tnf-\u03b1 in serum of patients with chronic hepatitis C and hepatic damage chronic and acute for alcohol consumption. Ann Hepatol. 2022. https:\/\/doi.org\/10.1016\/j.aohep.2021.100638.","journal-title":"Ann Hepatol"},{"key":"7070_CR47","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1471-2172-9-28","volume":"9","author":"L Barrett","year":"2008","unstructured":"Barrett L, Gallant M, Howley C, Bowmer MI, Hirsch G, Peltekian K, et al. Enhanced IL-10 production in response to hepatitis C virus proteins by peripheral blood mononuclear cells from human immunodeficiency virus-monoinfected individuals. BMC Immunol. 2008;9:1\u201316.","journal-title":"BMC Immunol"},{"key":"7070_CR48","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s43066-021-00108-5","volume":"11","author":"IS Naga","year":"2021","unstructured":"Naga IS, Kamel AAF, Ooda SA, Elbab HMF, El-Sharkawy RM. Effect of directly acting anti-viral agents on immunological imprints in chronic HCV-4a patients: interleukin-10 and vascular endothelial growth factor genes expression level. Egypt Liver J. 2021;11:1\u201310.","journal-title":"Egypt Liver J"},{"key":"7070_CR49","first-page":"249","volume":"15","author":"FA C\u00e3runtu","year":"2006","unstructured":"C\u00e3runtu FA, Benea L. Acute hepatitis C virus infection: diagnosis, pathogenesis, treatment. J Gastrointestin Liver Dis. 2006;15:249\u201356.","journal-title":"J Gastrointestin Liver Dis"},{"key":"7070_CR50","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.1136\/gutjnl-2014-308003","volume":"65","author":"ND Van","year":"2016","unstructured":"Van ND, Falk CS, Sandmann L, Vondran FW, Helfritz F, Wedemeyer H, et al. Modulation of HCV reinfection after orthotopic liver transplantation by fibroblast growth factor-2 and other non-interferon mediators. Gut. 2016;65:1015\u201323.","journal-title":"Gut"},{"key":"7070_CR51","doi-asserted-by":"crossref","unstructured":"Radmanic L, Zidovec-Lepej S. The Role of Stem Cell Factor, Epidermal Growth Factor and Angiopoietin-2 in HBV, HCV, HCC and NAFLD. Life (Basel). 2022;12.","DOI":"10.3390\/life12122072"},{"key":"7070_CR52","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1177\/15353702231181343","volume":"248","author":"A Araujo","year":"2023","unstructured":"Araujo A, Sgorlon G, Aguiar LE, Cidrao M, Teixeira KS, Villalobos Salcedo JM, et al. Influence of polymorphic variations of IFNL, HLA, and IL-6 genes in severe cases of COVID-19. Exp Biol Med (Maywood). 2023;248:787\u201397.","journal-title":"Exp Biol Med (Maywood)"},{"key":"7070_CR53","doi-asserted-by":"publisher","first-page":"21185","DOI":"10.1038\/s41598-021-00747-z","volume":"11","author":"JMR Saponi-Cortes","year":"2021","unstructured":"Saponi-Cortes JMR, Rivas MD, Calle-Alonso F, Sanchez JF, Costo A, Martin C, et al. IFNL4 genetic variant can predispose to COVID-19. Sci Rep. 2021;11:21185.","journal-title":"Sci Rep"},{"key":"7070_CR54","doi-asserted-by":"publisher","first-page":"340","DOI":"10.3389\/fcimb.2019.00340","volume":"9","author":"B Rugwizangoga","year":"2019","unstructured":"Rugwizangoga B, Andersson ME, Kabayiza JC, Nilsson MS, Armannsdottir B, Aurelius J, et al. IFNL4 genotypes predict clearance of RNA viruses in Rwandan children with upper respiratory tract infections. Front Cell Infect Microbiol. 2019;9:340.","journal-title":"Front Cell Infect Microbiol"},{"key":"7070_CR55","unstructured":"Bhattacharya D, Aronsohn A, Price J, Lo Re V, Panel A-IHG. Hepatitis C Guidance 2023 Update: AASLD-IDSA Recommendations for Testing, Managing, and Treating Hepatitis C Virus Infection. Clin Infect Dis. 2023."},{"key":"7070_CR56","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1093\/cid\/ciac821","volume":"76","author":"JS Jacob","year":"2023","unstructured":"Jacob JS, Shaikh A, Goli K, Rich NE, Benhammou JN, Ahmed A, et al. Improved survival after liver transplantation for patients with human immunodeficiency virus (HIV) and HIV\/hepatitis c virus coinfection in the integrase strand transfer inhibitor and direct-acting antiviral eras. Clin Infect Dis. 2023;76:592\u20139.","journal-title":"Clin Infect Dis"},{"key":"7070_CR57","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1186\/s12979-023-00365-5","volume":"20","author":"OB Parks","year":"2023","unstructured":"Parks OB, Eddens T, Sojati J, Lan J, Zhang Y, Oury TD, et al. Terminally exhausted CD8(+) T cells contribute to age-dependent severity of respiratory virus infection. Immun Ageing. 2023;20:40.","journal-title":"Immun Ageing"},{"key":"7070_CR58","doi-asserted-by":"publisher","first-page":"1233870","DOI":"10.3389\/fimmu.2023.1233870","volume":"14","author":"E Terrabuio","year":"2023","unstructured":"Terrabuio E, Zenaro E, Constantin G. The role of the CD8+ T cell compartment in ageing and neurodegenerative disorders. Front Immunol. 2023;14:1233870.","journal-title":"Front Immunol"},{"key":"7070_CR59","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1016\/j.ccell.2018.03.012","volume":"33","author":"DS Thommen","year":"2018","unstructured":"Thommen DS, Schumacher TN. T cell dysfunction in cancer. Cancer Cell. 2018;33:547\u201362.","journal-title":"Cancer Cell"},{"key":"7070_CR60","doi-asserted-by":"publisher","first-page":"1735","DOI":"10.1097\/QAD.0b013e3283601144","volume":"27","author":"P Unemori","year":"2013","unstructured":"Unemori P, Leslie KS, Hunt PW, Sinclair E, Epling L, Mitsuyasu R, et al. Immunosenescence is associated with presence of Kaposi\u2019s sarcoma in antiretroviral treated HIV infection. AIDS. 2013;27:1735\u201342.","journal-title":"AIDS"},{"key":"7070_CR61","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1016\/j.it.2009.03.013","volume":"30","author":"NP Weng","year":"2009","unstructured":"Weng NP, Akbar AN, Goronzy J. CD28(-) T cells: their role in the age-associated decline of immune function. Trends Immunol. 2009;30:306\u201312.","journal-title":"Trends Immunol"},{"key":"7070_CR62","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1038\/s41590-021-00949-7","volume":"22","author":"JL Collier","year":"2021","unstructured":"Collier JL, Weiss SA, Pauken KE, Sen DR, Sharpe AH. Not-so-opposite ends of the spectrum: CD8+ T cell dysfunction across chronic infection, cancer and autoimmunity. Nat Immunol. 2021;22:809\u201319.","journal-title":"Nat Immunol"},{"key":"7070_CR63","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2023.114664","volume":"162","author":"V Lara-Aguilar","year":"2023","unstructured":"Lara-Aguilar V, Valle-Millares D, Crespo-Bermejo C, Grande-Garcia S, Llamas-Adan M, Cortijo-Alfonso ME, et al. Dynamics of cellular senescence markers after HCV elimination spontaneously or by DAAs in people living with HIV. Biomed Pharmacother. 2023;162:114664.","journal-title":"Biomed Pharmacother"},{"key":"7070_CR64","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1186\/s12979-023-00387-z","volume":"20","author":"R Martin-Escolano","year":"2023","unstructured":"Martin-Escolano R, Vidal-Alcantara EJ, Crespo J, Ryan P, Real LM, Lazo-Alvarez JI, et al. Immunological and senescence biomarker profiles in patients after spontaneous clearance of hepatitis C virus: gender implications for long-term health risk. Immun Ageing. 2023;20:62.","journal-title":"Immun Ageing"},{"key":"7070_CR65","doi-asserted-by":"publisher","DOI":"10.3350\/cmh.2025.0292","author":"M Witte","year":"2025","unstructured":"Witte M, Oltmanns C, Tauwaldt J, Schmaus H, Mischke J, Grabert G, et al. Distinct inflammatory imprint in non-cirrhotic and cirrhotic patients before and after direct-acting antiviral therapy. Clin Mol Hepatol. 2025. https:\/\/doi.org\/10.3350\/cmh.2025.0292.","journal-title":"Clin Mol Hepatol"},{"key":"7070_CR66","doi-asserted-by":"publisher","DOI":"10.3390\/jcm13133936","volume":"13","author":"B Alvarez-Alvarez","year":"2024","unstructured":"Alvarez-Alvarez B, Prieto-Perez L, de la Cuadra-Grande A, Casado MA, Cabello Ubeda A, Al-Hayani AW, et al. The era of DAAs: assessing the patients\u2019 characteristics, clinical impact, and emergence of comorbidities in HIV\/HCV-coinfected versus HIV-infected individuals. J Clin Med. 2024;13:3936.","journal-title":"J Clin Med"}],"container-title":["Journal of Translational Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-025-07070-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12967-025-07070-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-025-07070-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,30]],"date-time":"2025-12-30T06:05:36Z","timestamp":1767074736000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12967-025-07070-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,30]]},"references-count":66,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["7070"],"URL":"https:\/\/doi.org\/10.1186\/s12967-025-07070-5","relation":{},"ISSN":["1479-5876"],"issn-type":[{"type":"electronic","value":"1479-5876"}],"subject":[],"published":{"date-parts":[[2025,12,30]]},"assertion":[{"value":"14 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was reviewed and approved by the Committee of the Institute of Health Carlos III (CEI PI 81_2017\u2010Enmienda 2022). The patients\/participants provided their written informed consent to participate in this study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors have no conflicts of interest to declare that are relevant to the content of this article.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"1432"}}